By Jake Crosby
In 2001, self-styled autism advocate Mark Blaxill failed to disclose his conflict of interest with pharmaceutical companies at the Institute of Medicine’s 2001 meeting on thimerosal and neurodevelopmental disorders. This non-disclosure would contradict what he would claim in a podcast interview 12 years later as Canary Party Chairman:
“The only time I had a conflict was when I was helping David Kirby and contributing to the Evidence of Harm book. And it’s even in the book, Curt; I have never hid the conflict. I’ve actually been public with people and open with people about the concerns I’ve had. So it’s not as though there is any great secrets I was keeping. And whatever concern I had, it is not operative any longer.”
But at his 2001 IOM presentation – discussed in “Evidence of Harm” – Blaxill said, after being introduced by IOM Committee Chair Marie McCormick:
“Thank you very much, Dr. McCormick. I am very pleased at the opportunity to present to the panel.
I had an easy time on the conflict of interest question. I am a parent, and I can guarantee you that the research that you will see has received no funding from anybody whatsoever. I also have an MBA, so I recognize that places me at something of a presumptive intellectual disadvantage. So be it.”
Other than identify himself as a parent, Blaxill revealed no conflict of interest whatsoever. He only stated that his research was not supported by any funding source as IOM requested that he disclose. What he did not reveal was that he was still in the employ of Boston Consulting Group, which still had vaccine manufacturers as clients. He would admit this in email to SafeMinds’ board of directors the following year and to omnibus attorney Mike Williams the year after that. Blaxill even consulted for Merck.
There is no evidence that his email to SafeMinds‘ board of directors in 2002 was made public prior to the 2005 publication of David Kirby’s book “Evidence of Harm”, in which the email’s contents were discussed. Blaxill’s email to Williams was not public until it was revealed last year on Autism Investigated. So prior to publication of “Evidence of Harm,” the only known public record of discussion concerning Blaxill’s potential conflicts was his non-disclosure of any such conflicts when he first presented to IOM in 2001.
Not disclosing his conflict of interest enabled him to win the trust of other parents present in the audience at that meeting. The following year, he would join SafeMinds‘ board of directors, enabling him to influence that organization’s agenda. When the rider to shield Eli Lilly and other thimerosal manufacturers was slipped into the Homeland Security Bill, Blaxill sent an email threatening to resign should SafeMinds slam the company for poisoning children. That was when he cited his own employer’s ties to pharmaceutical companies as his reason for threatening to resign from SafeMinds’ board . Remarkably, SafeMinds capitulated to Blaxill and he remained on SafeMinds’ board for another decade. His position further enabled him to do irreparable harm to the omnibus autism cases – denying justice to 4,900 vaccine injured children – and hijack the agenda of the 2012 congressional autism hearing as well as a tentatively scheduled 2014 congressional hearing.
Following public revelations of his 2012 hijacking, he left SafeMinds in 2013 but remains chairman of his own organization Canary Party that he founded in 2011. He continuously works to shield the scientific misconduct of CDC and its collaborators from exposure in a congressional hearing. Meanwhile, the evidence mounts that he was planted at the 2001 IOM meeting, as does the evidence for his “advocacy” being nothing more than carefully orchestrated infiltration by a man so unqualified to speak at the IOM, he even acknowledged that fact in his presentation.
Jake Crosby is editor of Autism Investigated. He is a 2011 graduate of Brandeis University with a Bachelor of Arts in both History and Health: Science, Society and Policy and a 2013 graduate of The George Washington University School of Public Health and Health Services with a Master of Public Health in Epidemiology. He currently attends the University of Texas School of Public Health where he is studying for a Ph.D. in Epidemiology.